Raphael Pharmaceutical Inc.
RAPH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $14,720 | $19,626 | $4,979 | $30,857 |
| - Cash | $20 | $50 | $19 | $40 |
| + Debt | $41 | $41 | $41 | $0 |
| Enterprise Value | $14,741 | $19,617 | $5,001 | $30,817 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$315 | -$425 | -$394 | -$319 |
| % Margin | – | – | – | – |
| Net Income | -$322 | -$429 | -$395 | -$326 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.016 | -0.022 | -0.021 | -0.017 |
| % Growth | 25.1% | -6.3% | -18.4% | – |
| Operating Cash Flow | – | -$209 | – | – |
| Capital Expenditures | – | $0 | – | – |
| Free Cash Flow | – | -$209 | – | – |